Other
Loans collectively evaluated for impairment
Citigroup Loans collectively evaluated for impairment increased by 1.1% to $750.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $692.26B to $750.97B. Over 5 years (FY 2020 to FY 2025), Loans collectively evaluated for impairment shows an upward trend with a 2.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
Metric ID:
other_financing_receivable_collectively_evaluated_for_im_e5b141Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $661.95B | $651.23B | $656.27B | $648.87B | $648.23B | $637.67B | $647.70B | $645.50B | $653.43B | $656.79B | $679.71B | $664.04B | $678.03B | $679.67B | $684.81B | $692.26B | $714.15B | $723.70B | $743.12B | $750.97B |
| QoQ Change | — | -1.6% | +0.8% | -1.1% | -0.1% | -1.6% | +1.6% | -0.3% | +1.2% | +0.5% | +3.5% | -2.3% | +2.1% | +0.2% | +0.8% | +1.1% | +3.2% | +1.3% | +2.7% | +1.1% |
| YoY Change | — | — | — | — | -2.1% | -2.1% | -1.3% | -0.5% | +0.8% | +3.0% | +4.9% | +2.9% | +3.8% | +3.5% | +0.8% | +4.3% | +5.3% | +6.5% | +8.5% | +8.5% |
Range$637.67B – $750.97B
CAGR+2.7%
Avg YoY Growth+2.9%
Median YoY Growth+3.2%
Current Streak8 quarters growth
Loans collectively evaluated for impairment at Other Companies
Frequently Asked Questions
- What is Citigroup's loans collectively evaluated for impairment?
- Citigroup (C) reported loans collectively evaluated for impairment of $750.97B in Q1 2026.
- How has Citigroup's loans collectively evaluated for impairment changed year-over-year?
- Citigroup's loans collectively evaluated for impairment increased by 8.5% year-over-year, from $692.26B to $750.97B.
- What is the long-term trend for Citigroup's loans collectively evaluated for impairment?
- Over 5 years (2020 to 2025), Citigroup's loans collectively evaluated for impairment has grown at a 2.4% compound annual growth rate (CAGR), from $660.56B to $743.12B.